Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 71205-498
14 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71205-498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A vertical bar chart showing percentages of patients reporting improvement across treatment groups. The x-axis lists Placebo (n=463), Sildenafil Citrate Tablets 25 mg (n=214), 50 mg (n=391), and 100 mg (n=380). The y-axis represents percentage improvement, with values increasing from 0 to 100%. The chart shows increasing patient-reported improvement with higher Sildenafil Citrate doses, from 24% for placebo up to 82% for the 100 mg dose.*
71205-498-10 (Sildenafiltab100mg30s)
Sildenafil 100 mg film coated tablets label by Proficient Rx LP. The label specifies 10 tablets per package, each containing sildenafil citrate equivalent to 100 mg sildenafil. Tablets are described as white, round, biconvex, with 'I' debossed on one side and '58' on the other. Manufactured by Hetero Labs Limited, Hyderabad, India. Storage temperature and safety warnings are indicated.*
Sildenafilfigure1 (Sildenafilfigure1)
Line graph depicting systolic blood pressure changes (in mmHg) over 24 hours post-dose, comparing Sildenafil 100 mg film-coated tablets with placebo. The x-axis represents time in hours from pre-dose to 24 hours, and the y-axis shows changes in systolic blood pressure. Two lines track differences between the Sildenafil and placebo groups over time.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph showing the change in blood pressure (mmHg) over time (hours) for two treatments: Placebo and a 10 mg dose of Cilnidipine. The x-axis represents time postdose in hours, and the y-axis represents the change in blood pressure in mmHg. The graph compares the blood pressure response between the placebo and the active treatment over an 8-hour period.*
Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting percent change in a variable over time postdose in hours up to 8 hours. Two data sets are shown with distinct lines and markers, labeled for comparison between placebo and Sildenafil 50 mg treatment groups.*
Sildenafilfigure4 (Sildenafilfigure4)
A line graph comparing the effects of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo over time after dosing, measured in hours. The vertical axis represents a variable labeled in mmHg, and the horizontal axis represents time in hours, showing trends over an 8-hour period.*
Sildenafilfigure5 (Sildenafilfigure5)
A line graph showing plasma concentration (ng/mL) over time post-dose (hours) for a commercial Sildenafil tablet. The graph depicts plasma levels peaking shortly after administration around 1 hour, then gradually declining over a 24-hour period.*
Sildenafilfigure6a (Sildenafilfigure6a)
A vertical bar chart illustrating the percentage of patients at endpoint categorized by baseline score. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percent of patients, ranging from 0 to 80%. Different bars are shaded or patterned to represent scores 0 through 5 as indicated in a legend beside the chart.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart showing the percentage of patients at the endpoint plotted against baseline scores ranging from 0 to 5. The chart uses different shades to represent multiple categories or groups, with a legend indicating six categories labeled 00, 1, 2, 3, 4, and 5.*
Sildenafilheterologo1 (Sildenafilheterologo1)
Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafilstructure (Sildenafilstructure)
Chemical structure of Sildenafil, showing its fused ring system with sulfonamide and piperazine moieties, alongside an associated molecule, likely representing a citrate salt form.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
